Ann: Thirteenth Supplementary Prospectus, page-51

I hear you mate.

It's been a battle of attrition as a shareholder.

Let's hope they have saved the best for last.

I don't necessarily believe we need an enormous harvest result for the sp to sustain & build upon.

We are still in a stage of infancy like it or not. We can test our patience however common sense, reasonable expectations & timelines must be applied to how we measure performance.

As long as the company can continually demonstrate the crop yields are materially improving, that they are on track towards mass scale harvesting & that revenue figures are beginning to have an air of dignity about them CGB should be fine.

The above alone should encourage significant investment.

A neat business plan that leverages the BioHealth deal & targets export to Asia sooner than later will also do wonders for the sp.